1. Home
  2. STC vs SRPT Comparison

STC vs SRPT Comparison

Compare STC & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stewart Information Services Corporation

STC

Stewart Information Services Corporation

HOLD

Current Price

$68.23

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$15.61

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STC
SRPT
Founded
1893
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
1994
2000

Fundamental Metrics

Financial Performance
Metric
STC
SRPT
Price
$68.23
$15.61
Analyst Decision
Buy
Hold
Analyst Count
3
29
Target Price
$81.00
$25.85
AVG Volume (30 Days)
215.8K
3.0M
Earning Date
04-22-2026
05-06-2026
Dividend Yield
3.00%
N/A
EPS Growth
55.17
N/A
EPS
0.55
2.88
Revenue
$2,921,636,000.00
$2,198,237,000.00
Revenue This Year
$13.62
N/A
Revenue Next Year
$7.13
N/A
P/E Ratio
$127.71
$5.39
Revenue Growth
17.32
15.58
52 Week Low
$57.11
$14.68
52 Week High
$78.61
$25.32

Technical Indicators

Market Signals
Indicator
STC
SRPT
Relative Strength Index (RSI) 55.36 36.12
Support Level $68.90 N/A
Resistance Level $72.91 $18.16
Average True Range (ATR) 2.36 0.90
MACD -0.10 -0.29
Stochastic Oscillator 67.74 8.92

Price Performance

Historical Comparison
STC
SRPT

About STC Stewart Information Services Corporation

Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments: Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: